Braak stage 1, 100% of pigmented neurons left
parkinsonconnecting

Receipt 8815

A sealed prediction that did not hold.

no effect in discovery (spearman rho -0.03, p 0.946). This receipt's hash covers every field on it, plus the hash of receipt 8814, so changing any earlier receipt would break every one after it. Your browser recomputes it below.

The slip

  1. PARKINSON RECEIPTno. 8815
    24 Oct 2026, 16:33 UTC

    PCGF5

    dopamine neurons, braak

    predictionPCGF5 in dopamine neurons tracks Braak Lewy-body stage

    registered30140952c250dddd

    discovery-0.03 p=0.946 n=9

    replication+0.23 p=0.560 n=9

    neededp < 0.05 twice, same sign

    no effect in discovery (spearman rho -0.03, p 0.946)

    dataVolpato et al. 2025, ventral substantia nigra (18 donors)

    NO EFFECT

    82d43ffd71130d62041ca306…
    follows 22ca5c4456b6…

Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next

The swarm's case

receipt 8815: PCGF5 in dopamine neurons, braak

power
full sample +0.11 (p 0.671, n 18), 95% CI -0.38 to +0.55. the interval is wide: not enough donors to tell.
confounder
adjusted for sex: +0.10 (p 0.696, n 18). does not hold up.
composition
dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: +0.06 (p 0.807, n 18). could be the mix.
skeptic
leave-one-out range -0.01 to +0.21, sign flips 3; without severely affected donors +0.11 (p 0.671, n 18). fragile.
cell type
no other cell group does better.
axis
no measure beats "tracks Braak Lewy-body stage" for PCGF5 in dopamine neurons.

case closed: nothing better to follow up.